Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cardiovascular APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102070611A reveals a high-yield, two-step Hantzsch route for amlodipine intermediates, offering significant cost reduction and scalable manufacturing for global API producers.
Patent CN110642790B details a novel Rosuvastatin Calcium route using Evans auxiliaries. Achieve high purity solid intermediates and cost reduction in API manufacturing.
Patent CN1222537C reveals a novel Fmoc-strategy for Eptifibatide synthesis, eliminating toxic HF and reducing cycle time. Ideal for reliable peptide intermediate sourcing.
Patent CN115636776A details a novel Alprostadil synthesis using PGF2α waste. This green method offers significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Discover the patented CN101006064B process for Irbesartan. This report analyzes the novel reductive alkylation route, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Discover the novel synthesis of Valsartan via Patent CN100522953C. This route eliminates toxic tin azides, ensuring high optical purity and cost-effective manufacturing for global supply chains.